[Lochein - a novel hepatoprotective drug].
A trial of a novel hepatoprotective plant drug lochein (Salsola extract) developed in Russia was performed in 110 patients with a verified chronic hepatitis of viral (73 patients) or alcohol (36 patients) etiology versus well-known hepatoprotector corsil given to 40 patients. Lochein demonstrated more potent effect than corsil.
Beloborodova
E I
EI
Saratikov
A S
AS
Vengerovskiĭ
A I
AI
Shalovaĭ
A A
AA
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000378:metabolism; D006519:Hepatitis, Alcoholic / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D010936:Plant Extracts / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods; D012838:Silymarin / Q000627:therapeutic use; D016896:Treatment Outcome
D000975:Antioxidants; D010936:Plant Extracts; D012838:Silymarin; C108292:lochein